Michael Webb, MBA.

Mike Webb has over 25 years of experience in healthcare and life sciences. Most recently, he was the CEO of Ascent Therapeutics, a venture-backed company focusing on developing pepducins, a new biology platform for drug discovery. Prior to founding Ascent, he was the CEO of EPIX Pharmaceuticals, Inc. from 1994 through 2005. During this period, EPIX grew from a venture-backed startup to the world leader in discovery and development of pharmaceuticals for imaging with MRI, achieving worldwide approval for its lead product and completing numerous public financings and corporate partnerships including an IPO. Mr. Webb joined EPIX from CIBA, where he was most recently Senior Vice President, Worldwide Marketing and Strategic Planning of CIBA Diagnostics, responsible for global marketing, program management, corporate planning, business development and licensing. Prior to CIBA, Mr. Webb was a senior consultant at Booz, Allen & Hamilton, specializing in healthcare and life sciences.

Mr. Webb holds Bachelors degrees in Biochemistry and Economics from the University of Kansas, Summa Cum Laude and an MA in International Relations from Sussex University in the UK, completing his thesis on “Pharmaceuticals Policy and the World Health Organization.” In addition, Mr. Webb holds an MBA degree with honors from the Kellogg Graduate School of Management at Northwestern University. He currently serves on the boards of the Massachusetts Biotechnology Council, where he is past Chairman, the Kellogg Center for Biotechnology at Northwestern and is a Senior Advisor to Johnston and Blakely, a life sciences investment banking firm.